- Home
- ROIV vs BEKE Comparison
ROIV vs BEKE Comparison
Compare ROIV & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | BEKE |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 18.4B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ROIV | BEKE |
|---|---|---|
| Price | $28.12 | $14.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $27.56 | $23.70 |
| AVG Volume (30 Days) | ★ 4.5M | 4.0M |
| Earning Date | 02-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $6.39 |
| Revenue Next Year | $594.84 | $9.69 |
| P/E Ratio | ★ N/A | $41.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $14.40 |
| 52 Week High | $30.33 | $22.25 |
Technical Indicators
Market Signals| Indicator | ROIV | BEKE |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 31.36 |
| Support Level | $26.94 | N/A |
| Resistance Level | $30.33 | $17.68 |
| Average True Range (ATR) | 0.95 | 0.45 |
| MACD | -0.12 | -0.10 |
| Stochastic Oscillator | 79.20 | 13.06 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BEKE KE Holdings Inc (each representing three)
KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.